Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmon

Company common stock to trade on Nasdaq under the symbol “IRLA” effective October 12, 2026Key Management changes include new CEO, Brigette Roberts, M.D.; new CFO, John Militello, CPA; and new COO Keith R. Fandrick, Ph.D.Board strengthened with the addition of Catherine Bonuccelli, M.D., Leone Patte…